MedPAC To The Rescue? How US Policy Advisors Could Save The Drug Industry

Letter D
Re-engineering Medicare Part D could help the pharma industry avoid more draconian price controls. • Source: shuttershock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet